135 related articles for article (PubMed ID: 32504685)
21. Skene's gland cyst excision.
Foster J; Lemack G; Zimmern P
Int Urogynecol J; 2016 May; 27(5):817-20. PubMed ID: 26670578
[TBL] [Abstract][Full Text] [Related]
22. Ureter metastatic castration-resistant prostate cancer: a case report.
Tsutsumi S; Kawahara T; Hattori Y; Mochizuki T; Teranishi JI; Miyoshi Y; Chiba S; Uemura H
J Med Case Rep; 2017 Sep; 11(1):215. PubMed ID: 28874180
[TBL] [Abstract][Full Text] [Related]
23. Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate.
Janzen BW; Ong A; Penner M; Koul R; Dubey A; Ahmed S; Bashir B; Chowdhury A; Dawe DE; Nayak J; Kim JO
Am J Clin Oncol; 2020 Dec; 43(12):865-871. PubMed ID: 32976179
[TBL] [Abstract][Full Text] [Related]
24. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
[TBL] [Abstract][Full Text] [Related]
25. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
26. A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Iwamura H; Hatakeyama S; Tanaka Y; Tanaka T; Tokui N; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Ohyama C
BMC Res Notes; 2014 Jan; 7():64. PubMed ID: 24476098
[TBL] [Abstract][Full Text] [Related]
27.
Akdemir EN; Tuncel M; Akyol F; Bilen CY; Baydar DE; Karabulut E; Ozen H; Caglar M
World J Urol; 2019 May; 37(5):813-821. PubMed ID: 30151600
[TBL] [Abstract][Full Text] [Related]
28. A rare case of primary female urethral adenocarcinoma: Columnar type with colonic adenocarcinoma features.
Gangadhar P; Pai MR; Sandhya I
Indian J Pathol Microbiol; 2018; 61(1):127-130. PubMed ID: 29567902
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. Female urethral adenocarcinoma: immunohistochemical evidence of more than 1 tissue of origin.
Murphy DP; Pantuck AJ; Amenta PS; Das KM; Cummings KB; Keeney GL; Weiss RE
J Urol; 1999 Jun; 161(6):1881-4. PubMed ID: 10332458
[TBL] [Abstract][Full Text] [Related]
31. Adenofibroma of Skene's Duct: A Case Report.
Chong Y; Eom M; Park KH; Chung HC; Ro JY
Patholog Res Int; 2010 Apr; 2010():318973. PubMed ID: 21152177
[TBL] [Abstract][Full Text] [Related]
32. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
33. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
34. Primary adenoid cystic carcinoma of Skene's glands.
Ali SZ; Smilari TF; Gal D; Lovecchio JL; Teichberg S
Gynecol Oncol; 1995 May; 57(2):257-61. PubMed ID: 7729746
[TBL] [Abstract][Full Text] [Related]
35. [Cyst of Skene's gland communicating with the urethra].
Castiñeiras J; Cabello Torres P; Sánchez del Pino MJ; Rodríguez-Rubio F
Actas Urol Esp; 1985; 9(3):259-62. PubMed ID: 4036690
[No Abstract] [Full Text] [Related]
36. Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
Abbas F; Kaplan M; Soloway MS
Br J Urol; 1996 Mar; 77(3):423-8. PubMed ID: 8814850
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of Skene's gland associated with urethral diverticulum: a case report.
Klotz PG
J Urol; 1974 Oct; 112(4):487-8. PubMed ID: 4369830
[No Abstract] [Full Text] [Related]
38. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
[TBL] [Abstract][Full Text] [Related]
39. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.
Garcia-Albeniz X; Chan JM; Paciorek A; Logan RW; Kenfield SA; Cooperberg MR; Carroll PR; Hernán MA
Eur J Cancer; 2015 May; 51(7):817-24. PubMed ID: 25794605
[TBL] [Abstract][Full Text] [Related]
40. Locally Metastatic Ductal Adenocarcinoma of the Prostate: A Therapeutic and Prognostic Dilemma.
DiIenno N; Edwards DC; McGreen B; Levy J; Zheng H; Foote C; Nordsiek MF; Mapow B; May NR; Amster MI
Urology; 2018 Dec; 122():10-12. PubMed ID: 30171919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
